OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 29 filers reported holding OPIANT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $328,000 | -10.4% | 30,500 | 0.0% | 0.21% | -5.9% |
| Q2 2022 | $366,000 | -44.0% | 30,500 | 0.0% | 0.22% | -36.9% |
| Q1 2022 | $653,000 | -39.3% | 30,500 | -4.7% | 0.35% | -36.8% |
| Q4 2021 | $1,076,000 | +30.6% | 32,000 | 0.0% | 0.56% | +23.2% |
| Q3 2021 | $824,000 | +92.5% | 32,000 | 0.0% | 0.45% | +102.7% |
| Q2 2021 | $428,000 | +25.9% | 32,000 | 0.0% | 0.22% | +20.5% |
| Q1 2021 | $340,000 | +32.3% | 32,000 | 0.0% | 0.18% | +17.8% |
| Q4 2020 | $257,000 | +16.3% | 32,000 | +8.5% | 0.16% | -3.7% |
| Q3 2020 | $221,000 | -16.9% | 29,500 | 0.0% | 0.16% | -18.1% |
| Q2 2020 | $266,000 | -25.9% | 29,500 | -21.3% | 0.20% | -32.1% |
| Q1 2020 | $359,000 | -30.7% | 37,500 | +4.2% | 0.29% | +17.7% |
| Q4 2019 | $518,000 | +2.8% | 36,000 | +7.5% | 0.25% | +16.4% |
| Q3 2019 | $504,000 | – | 33,500 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
| APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
| Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
| Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
| Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
| Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |